New York is proposing a rule that would require many workplaces — construction jobsites among them — to stock opioid antagonists like naloxone and train designated staff to use them, according to analysis from Ogletree and a related Construction Dive report on contractor preparedness for on-site overdoses.
Here's the plain version: an opioid antagonist is a drug that reverses an overdose in progress, and the proposal would put the responsibility on employers to have it on hand and have someone on-site who knows how to use it — the same logic as a first-aid kit or an AED, applied to overdose response. Construction has among the highest overdose death rates of any industry, which is the reason this rule is aimed squarely at job sites.
Who's affected: any New York employer that falls under the proposed workplace categories, which based on current reporting is expected to sweep in construction sites given the industry's documented overdose risk. The requirement would likely mean stocking naloxone in job-site first-aid stations and training a trailer super or safety officer to administer it — a new line item and a new training module, not a major cost, but a new mandatory one.
What it costs a contractor: budget for the kits themselves (inexpensive, typically under $50 per unit) and for training time for whoever gets designated on each site. The bigger ask is operational — making sure the kit and the trained person are actually on-site every day a crew is working, the same discipline required for first-aid certification today.
This rule is still a proposal, not yet final, so the effective date and exact jobsite thresholds aren't locked — contractors should track the formal rulemaking before budgeting line items, and this is not legal advice.